P-207: Pharmacogenetic Study of CYP19A1 (Aromatase) in Ovarian Induction in Iranian Polycystic Ovarian Syndrome Patients

Authors

  • Afsharian P
  • Ahmadi J
  • Akhlagi AA
  • Eftekhar Yazdi P
  • Ghezelayagh Z
  • Hassani F
  • Khosravifar M
  • Shiva M
Abstract:

Background: Hyper-androgenemia is one of the main clinical features of polycystic ovarian syndrome (PCOS). Letrozol is an aromatase inhibitor drug, which is co-administered with gonadotropins in most cases of PCOS, to improve ovulation. Aromatase has a critical role in catalyzing the conversion of androgens to estrogens and is responsible for keeping the homeostatic balance between them. Hence variations in its gene, CYP19A1, might be associated to syndromes of androgen excess such as PCOS. Materials and Methods: The aim of our study was to investigate polymorphisms of CYP19A1 gene in PCOS patients (55 people). The comparison was against 2 control groups which included 40 healthy fertile women and 45 women (with male factor infertility) under intra uterine insemination (IUI) treatment (drug response-control group). The study investigated the associations between above three groups and observed SNPs of CYP19. The expressions of CYP19A1 mRNA and protein in patients who had reached IVF treatment cycle was studied to compare with the observed polymorphisms. Results: PCR- RFLP was undertaken (exons 7, 9 and 10) on extracted DNA from blood samples to detect known functional polymorphisms of CYP19A1. Alterations of amino acids in the active site of exon 8, a TCT ins/del and a polymorphic TTTA repeat in intron 4 were also studied by sequencing. Finally the mRNA and protein expressions of 5 PCOS patients in comparison to 5 drug response-control patients was studied with real time and western blot techniques, respectively. Conclusion: No association was observed between SNPs of exons 7, 9 and 10 with PCOS. However, an association between polymorphism rs700519 in exon 7 and improvement of treatment (Follicular Diameter) was seen in cases who had taken Letrozol. No amino acid changes were observed in the active site of this gene. In addition, more studies must be done on the expression of CYP19A1 gene in both mRNA and protein levels.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

In Vitro Oocyte Maturation in Polycystic Ovarian Syndrome Patients

Prevalence of Polycystic Ovarian Syndrome(PCOS) in Iran is more than 6%. Therefore we encounter with many PCOS patients. In Vitro Maturation (IVM) of oocytes as an attractive method in ART is considered. Studies show that changes in culture conditions should be administered to make IVM protocol more successful .For this purpose in this study we have set up the beneficial cultures for IVM proced...

full text

P-199: Comparison of Clomiphene Citrate and Letrozole Effect on Folliculogenesis in Polycystic Ovarian Syndrome Patients

Background: Polycystic ovarian syndrome (PCOS) which is the most common form of anovulatory infertility affects 5-10% women of reproductive age. Clomiphene Citrate (C.C) is the first line treatment in infertile women entering intrauterine insemination (IUI) cycle. For C.C resistant patients the second approach is aromatase inhibitors such as Letrozole. The aim of this study is to compare the ef...

full text

Ovarian Polycystic Induction with Morphine in Wistar Rat

Background and Objective: The effect of opioids on the reproductive system has been studied as an attractive research field. In this study, the effect of morphine as an analgesic opioid was evaluated on the ovarian polycystic induction in the rat. Materials & Methods: In this study, 24 female virgin Wistar rats weighing 200-250 g were injected with morphine (1-10 mg/kg/day) for 9 days. Control ...

full text

Factors Influencing the Outcome of Laparoscopic Ovarian Electerocauterization in Women with Polycystic Ovarian Syndrome

Background/Objective: To evaluate factors which increase the chance of ovulation and pregnancy after laparoscopic ovarian electerocauterization (LEC) in Clomiphene Citrate (CC) resistant polycystic ovarian syndrome (PCOS) patients.Methods: An experimental prospective study was carried out in the infertility division of a university teaching hospital. Two hundred and ninety-nine women with PCOS ...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 7  issue 3

pages  117- 117

publication date 2013-09-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023